![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 17, Issue 10, 4400-4410, October 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Department of Cell and Molecular Biology/Microbiology, Göteborg University, S-405 30 Göteborg, Sweden; Cell Signaling Unit, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), E-08003 Barcelona, Spain; ||Department of Chemistry, Atmospheric Science, Göteborg University, S-412 96, Göteborg, Sweden; and ¶Institute of Genetics and Microbiology, Wroclaw University, 51-148 Wroclaw, Poland
Submitted April 17, 2006;
Revised June 19, 2006;
Accepted July 24, 2006
Monitoring Editor: Charles Boone
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
sensitivity is accompanied by elevated cellular arsenic levels and we demonstrate that increased arsenite influx is dependent on the aquaglyceroporin Fps1p. Fps1p is phosphorylated on threonine 231 in vivo and this phosphorylation critically affects Fps1p activity. Moreover, Hog1p is shown to affect Fps1p phosphorylation. Our data are the first to demonstrate Hog1p activation by metalloids and provides a mechanism by which this kinase contributes to tolerance acquisition. Understanding how arsenite/antimonite uptake and toxicity is modulated may prove of value for their use in medical therapy. |
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
). In spite of its toxicity, arsenic-containing drugs are part of modern therapy. Arsenic trioxide is used as a treatment for acute promyelocytic leukemia and has also been tested for treatment of hematological and solid cancers (Evens et al., 2004). Drugs containing arsenic, or the related metalloid antimony, are currently used to treat diseases caused by the protozoan parasites Trypanosoma and Leishmania (Murray, 2001; Barrett et al., 2003). For the effective use of metalloid-containing drugs in medical therapy, it is imperative to understand the function and regulation of uptake pathways, of proteins that modulate the activity of such pathways, as well as of systems mediating detoxification and tolerance at the molecular level.
Pathways related to metalloid uptake and detoxification have been identified in the eukaryotic model organism Saccharomyces cerevisiae (budding yeast) as well as in other organisms (Tamás and Wysocki, 2001; Rosen, 2002; Tamás et al., 2005). Arsenite [As(III)] and antimonite [Sb(III)] enter budding yeast through the aquaglyceroporin Fps1p (Wysocki et al., 2001). In fact, aquaglyceroporins constitute As(III) and Sb(III) entry routes in bacteria (Sanders et al., 1997; Meng et al., 2004), Leishmania (Gourbal et al., 2004), mammals (Liu et al., 2002), and humans (Bhattacharjee et al., 2004). Besides Fps1p, As(III) influx in yeast also involves hexose permeases (Liu et al., 2004). Two independent transport systems contribute to metalloid removal from the yeast cytosol; Acr3p mediates As(III) efflux from the cell, whereas the ABC-transporter Ycf1p sequesters glutathione-conjugates of As(III) and Sb(III) in the vacuole (Wysocki et al., 1997; Ghosh et al., 1999). Hence, besides regulated uptake and efflux, metalloid complexation, and compartmentalization contribute to cellular tolerance.
Importantly, the activity of metal influx and detoxification systems is controlled by signaling proteins and transcriptional regulators; yet, our understanding of the mechanisms by which eukaryotic cells sense the presence of metalloids and activate various tolerance systems is rudimentary. In mammals, As(III) activates the mitogen-activated protein kinase (MAPK) p38, which in turn activates transcription of various stress responsive genes via an AP-1 transcription factor (Cavigelli et al., 1996; Elbirt et al., 1998). Similarly, arsenic tolerance in the fission yeast Schizosaccharomyces pombe involves the MAPK Sty1 and the AP-1–like transcription factor Pap1 (Rodriguez-Gabriel and Russell, 2005). In S. cerevisiae, two AP-1–like transcription factors, Yap1p and Yap8p, contribute to tolerance by activating expression of separate subsets of detoxification genes (Wysocki et al., 2004). However, the molecular mechanisms through which these proteins mediate tolerance are not fully understood.
S. cerevisiae Hog1p is homologous to p38 and Sty1 and is the ultimate MAPK of the high osmolarity glycerol (HOG) pathway (Brewster et al., 1993; Figure 1). Osmotic stress activates Hog1p through two independent upstream branches that converge at the MAPKK Pbs2p. Sln1p is a negative regulator of the pathway and it controls the related MAPKKKs Ssk2p and Ssk22p through a phospho-relay system involving Ypd1p and Ssk1p (Maeda et al., 1994; Posas et al., 1996). The second branch involves the transmembrane protein Sho1p that recruits Pbs2p to the cell surface together with the MAPKKK Ste11p and its regulators Ste20p, Ste50p, and Cdc42p (Maeda et al., 1995; Posas and Saito, 1997; Posas et al., 1998; Raitt et al., 2000; Reiser et al., 2000). Like other MAPKs, Hog1p is activated by dual phosphorylation of adjacent threonine (T174) and tyrosine (Y176) residues. In turn, Hog1p activates its targets including several transcription factors (Rep et al., 1999; Alepuz et al., 2001; Proft et al., 2001; de Nadal et al., 2003), the MAPK-activated protein (MAPKAP) kinase Rck2p involved in translation control (Bilsland-Marchesan et al., 2000; Teige et al., 2001), and the cyclin-dependent kinase-inhibitor protein Sic1p (Escoté et al., 2004). In addition, Hog1p has been shown to phosphorylate the membrane transporters Tok1p and Nha1p (Proft and Struhl, 2004). The activity of the pathway is also controlled by two phospho-tyrosine phosphatases (Ptp2p and Ptp3p) and three phospho-serine/threonine phosphatases (Ptc1p-3p) that act on Hog1p (Maeda et al., 1994; Jacoby et al., 1997; Wurgler-Murphy et al., 1997; Warmka et al., 2001; Young et al., 2002).
|
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
and metalloid sensitivity assays were carried out as previously described (Wysocki et al., 2001). The plasmid pRS1 contains the HOG1 gene fused to a 3xHA-epitope at the N-terminus in pRS426 (2µ, URA3; Bell and Engelberg, 2003). To create the kinase dead and unphosphorylatable alleles of Hog1p, a 1-kb ClaI-AatII fragment from pBS15-HOG1-K52R and pBS15-HOG1-T174A/Y176F (kindly provided by D. Engelberg) respectively, was placed into pRS1 cleaved with the same enzymes. The plasmid pVR-65wt containing HOG1-GFP (Reiser et al., 1999) and the plasmids containing FPS1, FPS1-1, and FPS1-T231A fused to the c-myc epitope (Tamás et al., 1999, 2003) have been described elsewhere. The N-terminal hydrophilic tail of Fps1p covering amino acids 2–251 was inserted into the expression vector pGEX-4T-1 to allow expression of GST-Fps1p in Escherichia coli.
|
24 h before addition of high As(III) concentration (1.0 mM). Cells were collected at the time points indicated in the figures, washed in ice-cold water, and pelleted by centrifugation. The cell pellet was resuspended in water, boiled for 10 min, and centrifuged and the supernatant was collected. The arsenic content of each sample was determined using a graphite furnace atomic absorption spectrometer (SIMAA 6000; Perkin Elmer-Cetus) as described previously (Wagner and Boman, 2004). To measure arsenic efflux, we first exposed cells to 1.0 mM As(III) to allow accumulation. Cells were then washed once and resuspended in YNB glucose medium without As(III). The intracellular arsenic content was determined as above in cells collected immediately after washing (time point 0) and at the time points described in the figure. The amount of intracellular arsenic at time zero was set to 1. Arsenic measurements were performed at least three times and the values are given with SD.
Glycerol Uptake Assay
Yeast cells were grown in liquid YNB medium to an OD600 of 2.0, harvested, washed, and resuspended in ice-cold MES buffer (10 mM MES, pH 6.0) to a density of 40–60 mg of cells/ml. Glycerol uptake was measured by adding glycerol to a final concentration of 100 mM "cold" glycerol plus 40 µM [14C]glycerol (160 mCi/mmol; Amersham Biosciences, Piscataway, NJ) as described previously (Tamás et al., 1999, 2003). The uptake assays were repeated at least three times and the values are given with SD.
Membrane Preparation and Western Analysis
Yeast membranes were prepared as previously described (Tamás et al., 1999). Total protein, 10 µg, was separated by SDS-PAGE and blotted onto nitrocellulose filters. To detect Fps1p, the filters were probed with mouse monoclonal anti-c-myc (Roche Diagnostics, Indianapolis, IN) as primary antibody and horseradish peroxidase-conjugated anti-mouse IgG as secondary antibody (Promega, Madison, WI). The filters were incubated with ECL Plus Western blotting detection reagent (Amersham) and visualized using LAS-100 image reader (Fuji Film, Tokyo, Japan). For phosphatase treatment, protein extracts were incubated with 
-phosphatase (200 U, 15 min, 30°C). For phosphatase inhibition 24 µM sodium orthovanadate was added to the reaction. The amount of phosphorylated Fps1p was determined by quantifying the two electrophoretic mobility forms of Fps1p using the Multi Gauge software (Fuji Film). The level of phospho-Fps1p is given relative to total Fps1p.
Hog1p Phosphorylation Assays
Exponentially growing yeast cells were exposed to sodium arsenite (0.5 mM), potassium antimonyl tartrate (5 mM), or sodium chloride (0.4 M), and protein samples were prepared, separated by SDS-PAGE, and visualized as described previously (Tamás et al., 2000). A rabbit polyclonal IgG antibody against dually phosphorylated p38 (9211S, Cell Signaling Technology, Beverly, MA) was used to detect phosphorylated Hog1p whereas a goat polyclonal IgG antibody (yC-20, Santa Cruz Biotechnology, Santa Cruz, CA) was used to detect total Hog1p.
Fluorescence Microscopy
To analyze the distribution of Hog1p, transformants expressing a Hog1p-GFP fusion protein were grown in YNB medium lacking the appropriate amino acid to midlog phase. To visualize DNA, 2 µg/ml 4',6-diamino-2-phenylindole (DAPI) was added directly to the culture. Cells were washed twice with water or phosphate-buffered saline and GFP signals were observed in living cells before and after exposure to 1 mM As(III), 10 mM Sb(III), or 0.4 M NaCl using a Leica DM R fluorescence microscope (Deerfield, IL).
RNA Isolation, cDNA Synthesis, Microarray Hybridization, and Analysis
Total RNA was isolated as described previously (de Winde et al., 1996) from exponentially growing yeast cells either untreated or exposed to sodium arsenite (1 mM) for 1 h. Cy3/Cy5-labeled cDNA was generated from 20 µg of total RNA. The microarray slides (Yeast 6.4k array from UHN Microarray Centre, Toronto, Canada) were hybridized and scanned on a GenePix 4000 (Axon Instruments, Foster City, CA). cDNA synthesis and hybridization were done according to the slide manufacturer's protocols (www.microarrays.ca). Image segmentation and spot quantification was performed with the GenePix software (Axon Instruments). The microarray data were analyzed using R and the Bioconductor package LIMMA (Linear Models for Microarray Analysis). To avoid intensity-dependent trends, each array was normalized by subtracting a loess line from the M-values. The genes were ranked by a moderated (penalized) t-statistics to avoid false positives. Each microarray analysis was repeated with at least three independent experiments.
In Vitro Kinase Assays
In vitro kinase assays were carried out with GST-Hog1p and GST-Pbs2pEE (constitutively activated version of Pbs2p; de Nadal et al., 2003) expressed and purified from E. coli. Kinase assays were performed in a 40-µl reaction volume, with a mixture of [
-32P]ATP (5 µCi) and cold ATP (final concentration 50 µM). Kinases were preincubated for 20 min at 30°C and then assayed in the presence of the indicated substrate for 10 min.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Elbirt et al., 1998; Rodriguez-Gabriel and Russell, 2005). To examine whether the p38 and Sty1 homologue Hog1p has a similar role in S. cerevisiae, we first monitored growth of hog1 in the presence of metalloid salts. The hog1 mutant was highly sensitive to both As(III) and Sb(III) (Table 2), whereas it was unaffected by As(V) (Table 3). Based on the minimal inhibitory concentration (MIC), hog1 was, respectively, fourfold more As(III)-sensitive (0.3 vs. 1.2 mM) and 30-fold more Sb(III)-sensitive (0.5 mM vs. 15 mM) than the wild type (Table 2).
|
|
, but encompassed mutants lacking upstream pathway components. The MIC of pbs2 was identical to that of hog1 on both As(III) and Sb(III). The MIC of ssk1 on As(III) (0.4 mM) was very similar to that of hog1 and pbs2 (both 0.3 mM). Deletion of SSK2 produced an intermediate phenotype (MIC of 0.7 mM), whereas deletion of SSK22 only affected As(III) tolerance to a minor extent (MIC of 1.0 mM). SHO1 deletion caused a slight growth defect (MIC of 1.0 mM), whereas ste11 had the same intermediate As(III) sensitivity as ssk2 (MIC of 0.7 mM; Table 2).
We extended the phenotypic analysis of the HOG pathway by including various double mutants (Table 2). The MICs of double mutants lacking HOG1 were identical to that of single hog1 on both As(III) and Sb(III). The ssk1 sho1 mutant (MIC of 0.3 mM), where both branches are inactivated, was as As(III)-sensitive as hog1 and slightly more sensitive than ssk1 alone (MIC of 0.4 mM). The double mutants ssk2 sho1 (MIC of 0.4 mM) and ssk2 ste11 (MIC of 0.5 mM) were more sensitive than any of the single mutants but not as sensitive as hog1, suggesting that some Hog1p activation occurs in these mutants, possibly through Ssk22p (Figure 1). In contrast to As(III), the effect of Sb(III) on the single mutants was less pronounced, albeit some growth inhibition was observed at higher concentrations (Table 2). However, double mutants with both branches inactivated were as Sb(III)-sensitive as hog1 and pbs2 (MIC of 0.5 mM). We also note that none of the HOG-pathway mutants displayed As(V) sensitivity (our unpublished data). We conclude that Hog1p as well as components required for Hog1p activation are important for metalloid tolerance in S. cerevisiae. In particular, the Sln1p-Ssk1p branch appears to play a more prominent role in arsenite tolerance than the Sho1p-Ste11p branch.
We also investigated whether Hog1p would mediate metalloid tolerance through the AP-1–like transcription factors Yap1p and Yap8p (Wysocki et al., 2004). For this purpose, we created hog1, yap1 and yap8 deletion mutants in various combinations and determined the MIC of metalloids for these mutants (Table 3). Additive metalloid sensitivities were observed for the hog1 yap1 and hog1 yap8 double mutants as well as for the triple mutant hog1 yap1 yap8 (Table 3). Although phenotype analysis does not exclude that Hog1p acts through these proteins, it clearly indicates that Hog1p mediates metalloid tolerance through additional factors (see further).
Hog1p Activity Critically Affects Metalloid Tolerance
To test whether Hog1p kinase activity is critical for its function under metalloid exposure, we generated two versions of Hog1p: one that cannot be phosphorylated by Pbs2p (Hog1pT174A/Y176F) and one that can be phosphorylated but lacks kinase activity (Hog1pK52R; Reiser et al., 1999). When transformed into hog1, none of these HOG1 alleles were able to complement the sensitivity of hog1 on plates with As(III), Sb(III), or NaCl, whereas growth of transformants expressing wild-type HOG1 was unaffected (Figure 2A and our unpublished data). Next, we tested whether elevated Hog1p kinase activity would have the opposite effect, i.e., increased tolerance, by analyzing growth of a mutant lacking the tyrosine phosphatases Ptp2p and Ptp3p. These phosphatases have been shown to act on Hog1p, and basal MAPK activity is 10-fold higher in ptp2 ptp3 compared with that in the wild type (Jacoby et al., 1997; Wurgler-Murphy et al., 1997; Winkler et al., 2002). As shown in Figure 2B, ptp2 ptp3 was clearly more As(III) tolerant than the wild type. Importantly, elevated tolerance of ptp2 ptp3 was fully dependent on the presence of Hog1p because a triple ptp2 ptp3 hog1 mutant was as As(III) sensitive as hog1 (Figure 2B). Hence, Hog1p activity critically affects metalloid tolerance: impaired Hog1p function leads to sensitivity, whereas elevated activity results in improved tolerance.
|
15–30 min, and lasted up to 45 min (Figure 3B). Interestingly, this phosphorylation displayed quantitative and qualitative differences compared with phosphorylation during osmotic stress: maximal Hog1p phosphorylation was observed already within 5 min in response to 0.4 M NaCl and no phosphorylation was detected at 15 min (Figure 3B; lower panel). Consistently, maximal phosphorylation of the kinase-dead Hog1pK52R allele was reached later in response to As(III) (30 min) than to NaCl (5 min; Figure 3C). The sustained response in Figure 3C is due to a lack of feedback inhibition and down-regulation of HOG signaling, which requires the kinase activity of Hog1p (Wurgler-Murphy et al., 1997). Hence, Hog1p phosphorylation clearly displays different dynamics in response to As(III) and high osmolarity. Phospho-Hog1p was also detected in Sb(III) exposed cells, although in this case the signal was even weaker than in As(III)-treated cells (our unpublished data).
|
, ssk1, ssk1 sho1, and ssk2 ste11 mutants, whereas phosphorylation appeared unaffected in sho1, ssk2, and ste11. The lack of Hog1p phosphorylation in pbs2, ssk1, ssk1 sho1, and ssk2 ste11 is consistent with the observation that these mutants are as As(III)-sensitive as hog1 displaying nearly identical MICs (Figure 3D and Table 2). Hog1p-phosphorylation was present in ssk2 and ste11 despite that these mutants display some As(III) sensitivity. The fact that these MAPKKKs are involved in multiple pathways (Yuzyuk et al., 2002; Schwartz and Madhani, 2004) may explain this observation. Collectively, genetic and biochemical data strongly suggest that As(III)-activation of Hog1p principally occurs through the Sln1p-Ssk1p branch of the HOG pathway. In contrast, Sb(III)-activation of Hog1p can probably occur through either branch because only mutants where both branches were inactivated displayed Sb(III) sensitivity.
As(III)-activated Hog1p Remains Largely Cytoplasmic and Does Not Mediate a Major Transcriptional Response
To examine whether the relatively low level of Hog1p phosphorylation triggered by As(III) (compared with osmotic stress) is sufficient to promote its nuclear accumulation and gene-target activation, we transformed yeast cells with a plasmid expressing Hog1p-GFP under the control of the endogenous HOG1 promoter and monitored the fusion protein by fluorescence microscopy. In contrast to NaCl-treated cells where the majority of Hog1p-GFP was nuclear within 10 min of exposure (colocalization with DAPI; our unpublished data), Hog1p-GFP remained mainly cytoplasmic in the presence of As(III) and Sb(III) even after 1 h (Figure 4 and our unpublished data). Hence, Hog1p does not concentrate in the nucleus in response to metalloids.
|
cells. Here, we only report on the role of Hog1p in the transcriptional response to As(III) because a full analysis of these data is beyond the scope of this article and will be described elsewhere (Thorsen et al., unpublished results). Nevertheless, As(III) has a profound effect on the transcriptome; mRNA levels of 700 genes display a twofold increase/decrease (1 mM As(III) for 1 h), and Yap1p and Yap8p control expression of distinct subsets of As(III)-responsive genes (Haugen et al., 2004 and Thorsen et al., unpublished results). However, HOG1 deletion affected As(III)-induced expression of only four genes, namely ALD3, GRE1, HSP12, and YHR209W (our unpublished data). This is in clear contrast to osmotic stress where the kinase controls expression of several hundreds of genes (Posas et al., 2000; Rep et al., 2000; O'Rourke and Herskowitz, 2004). The proteins encoded by these four genes do not appear to play a major role in As(III) tolerance, because none of the corresponding deletion mutants were As(III) sensitive (our unpublished data). Together with the localization data above, we conclude that Hog1p does not promote a major reprogramming of the yeast transcriptome in the face of As(III) treatment. Instead, it is possible that Hog1p mediates metalloid tolerance by activating cytoplasmic targets.
The hog1 Mutant Displays Elevated Cellular As(III) Levels
Because arsenite and antimonite are toxic once they enter cells, we reasoned that Hog1p may affect intracellular metalloid levels. To test this, we first pre-exposed cells to 0.1 mM As(III) for 24 h (pre-exposure is required to correctly assess the contribution of Acr3p to As(III) efflux; Ghosh et al., 1999), added 1 mM As(III) for 60 min, and compared the cellular arsenic content before and after adding the higher concentration. Interestingly, hog1 accumulated 3–4-fold more arsenic than the wild type after 60 min of As(III) exposure (see further). In comparison, cells lacking FPS1 accumulated little As(III), whereas acr3 had 7-fold higher As(III) content than the wild type (our unpublished data). The elevated cellular arsenic content in hog1 is likely to be caused by reduced export, increased uptake, or a combination of both.
Hog1p Does Not Affect Acr3p-dependent As(III) Efflux
To address whether Hog1p affects Acr3p-dependent As(III) efflux, we scored growth of cells lacking either HOG1, ACR3, or both on As(III)-containing plates. Phenotypic analysis clearly established that the double mutant acr3 hog1 was more sensitive than any of the single mutants (Figure 5A). Next, we analyzed induction of ACR3 expression in As(III)-exposed wild-type and hog1 cells by using an ACR3 promoter-lacZ reporter construct (Wysocki et al., 2004). 
-galactosidase activity measurements indicated that metalloid-stimulated ACR3 expression is independent of Hog1p, which is also in agreement with the microarray data (our unpublished data). Together, phenotypic and gene expression analyses suggested that Acr3p mediates As(III) efflux independently of Hog1p. To confirm this notion, we exposed wild type, hog1, acr3, and acr3 hog1 to 1 mM As(III) to allow intracellular accumulation and then washed and resuspended the cells in As(III)-free medium and monitored intracellular arsenic levels in a time-course experiment. As shown in Figure 5B, wild-type and hog1 cells rapidly reduced the cellular arsenic content by 50% within the first 20 min. In contrast, acr3 and acr3 hog1 cells were unable to rapidly export arsenic under these conditions and only reduced the cellular level by 20–40% after 1 h. We conclude that Hog1p does not affect Acr3p-mediated As(III) efflux.
|
may be a result of increased uptake via the aquaglyceroporin Fps1p, we monitored growth of FPS1 and HOG1 mutants in the presence of metalloids. As reported before, hog1 was metalloid sensitive whereas fps1 was highly resistant (Figure 6A and Wysocki et al., 2001). Importantly, the hog1 fps1 double mutant was as resistant to As(III) and Sb(III) as the single fps1 mutant, and growth of hog1 fps1 was scored in the presence of up to 6 mM As(III) (Figure 6A and our unpublished data). Hence, epistasis analysis places FPS1 downstream of HOG1. The fact that FPS1 deletion suppressed the metalloid sensitivity of hog1 suggests that Fps1p-dependent metalloid uptake might increase in the absence of Hog1p. Indeed, transport assays confirmed that arsenic uptake was higher in hog1 than in the wild type, whereas uptake was very low in fps1 (Figure 6B). In agreement with the growth data, the hog1 fps1 mutant had the same low As(III) uptake as fps1 (Figure 6B). We also note that hog1 accumulated more arsenic during the pre-exposure than the wild type (see time point 0).
|
and acr3 with a plasmid encoding an FPS1 allele (FPS1-1) that exhibits high level of unregulated transport activity; the Fps1p-1 protein lacks amino acids 13–230 of the hydrophilic N-terminal tail that plays a crucial role in controlling Fps1p regulation and activity (Tamás et al., 1999; Wysocki et al., 2001). hog1 and acr3 were also transformed with an empty plasmid as a control. Growth of the transformants on As(III)-containing plates showed that expression of FPS1-1 increased As(III) sensitivity of acr3, whereas hog1 was not further sensitized by the presence of FPS1-1 (Figure 6C), 1) confirming that Acr3p and Fps1p act in separate pathways and 2) suggesting that HOG1 deletion or expression of the FPS1-1 allele increases Fps1p-dependent As(III) influx to similar degrees. To test the latter, we measured arsenic accumulation in wild-type and hog1 cells expressing either the wild-type copy of FPS1 or the FPS1-1 allele (Figure 6D). Uptake measurements established that As(III) influx is identical in hog1 expressing FPS1 or FPS1-1 and that expression of FPS1-1 in wild-type cells increased As(III) influx to the same degree as deletion of HOG1 did. We conclude that metalloid sensitivity of hog1 is to a large part (but not exclusively) attributable to increased Fps1p-dependent influx. Moreover, HOG1 deletion or Fps1p activation (by introducing the FPS1-1 allele) has the same consequence in terms of As(III) uptake and in terms of phenotype.
Hog1p Affects Fps1p Transport Activity in the Absence of Stress Treatments
To address whether Hog1p modulates the basal transport activity of Fps1p, i.e., in the absence of stress treatment, we compared transport of glycerol in wild-type and hog1 by measuring influx of radiolabeled glycerol. We have previously shown that under the conditions used here, Fps1p is responsible for the majority of glycerol influx into cells (Tamás et al., 1999, 2003). Interestingly, HOG1 deletion resulted in a 2–3-fold increase in glycerol uptake (3.3 ± 2.0 vs. 10.6 ± 2.9 mmol glycerol g–1 h–1: initial uptake rates in wild type and hog1, respectively) compared with the wild type. We confirmed by Western blot analysis that Fps1p protein levels were the same in wild-type and hog1 cells under the experimental conditions used for As(III) and glycerol transport experiments (our unpublished data). Moreover, FPS1 gene expression was similar in wild-type and hog1 cells before and during As(III) exposure (our unpublished data). Hence, Hog1p affects Fps1p transport activity also under basal conditions.
Fps1p Is Phosphorylated on Threonine 231
The most straight-forward interpretation of the data above is that Hog1p controls Fps1p activity by phosphorylating (a) critical residue(s) within the Fps1p N-terminal tail. To address this issue, we first asked whether Fps1p is phosphorylated in vivo. Immunological detection of full-length Fps1p fused to the c-myc epitope revealed that Fps1p is present in membrane extracts in two forms displaying different mobilities (Figure 7A, panel 1). The slower mobility form of Fps1p represents phophorylated Fps1p, since this form was not detected in phosphatase-treated extracts. A search for putative phosphorylation sites within Fps1p revealed a conserved MAPK phosphorylation site (PxTP) in its N-terminal tail (threonine 231). Interestingly, mutation of this threonine into alanine (T231A) was previously shown to produce a high level of unregulated transport activity through Fps1p, which is similar to that observed for Fps1p-1 (Tamás et al., 1999, 2003). Importantly, electrophoretic mobility of Fps1p-T231A was indistinguishable from that of phosphatase-treated wild-type Fps1p (Figure 7B), demonstrating that Fps1p is phosphorylated on T231 in vivo. Moreover, expression of Fps1p-T231A clearly sensitized cells to As(III) (Figure 7C), underscoring the importance of T231 phosphorylation for (control of) Fps1p transport activity.
|
extracts, although phosphorylated Fps1p appeared less abundant in hog1 compared with wild-type cells (Figure 7A, panel 3). Quantifying the abundance of the slower mobility form of Fps1p (phospho-Fps1p) in wild-type and hog1 cells (from 10 independent experiments) showed that HOG1 deletion reduces Fps1p phosphorylation 25% (Figure 7E) in vivo. Interestingly, we also observed an overall increase in Fps1p phosphorylation upon As(III)-treatment (Figure 7A, panel 2). However, quantifications indicated that this (increased) phosphorylation is independent of Hog1p (Figure 7A, panel 4, and our unpublished data). Hence, other kinases might also phosphorylate Fps1p on T231, at least in the absence of Hog1p. Nevertheless, although HOG1 deletion did not fully abolish Fps1p phosphorylation, our data clearly indicates that Fps1p phosphorylation by Hog1p critically affects activity of this aquaglyceroporin. |
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Kyriakis and Avruch, 2001). S. cerevisiae Hog1p was for long thought to be activated exclusively by osmotic stress but recent studies have implicated this MAPK in mediating tolerance to a variety of stress conditions including heat (Winkler et al., 2002), oxidative (Singh, 2000; Rep et al., 2001; Bilsland et al., 2004; Haghnazari and Heyer, 2004) and citric acid stress (Lawrence et al., 2004). Hog1p phosphorylation has been shown to require Sho1p under heat stress (Winkler et al., 2002), whereas phosphorylation by citric acid stress required Ssk1p (Lawrence et al., 2004). Through what branch oxidative stress activates Hog1p has not been firmly established. Here, we showed that As(III)-induced phosphorylation, and hence activation of Hog1p, displayed both quantitative and qualitative differences to osmotic activation; the signal was weaker, lasted longer, and was dependent on the Sln1p-Ssk1p branch of the pathway. Sb(III) activation of Hog1p is likely to involve both branches, as judged by the observation that both branches had to be inactivated to produce Sb(III) sensitivity.
The most striking feature of As(III)-triggered Hog1p activation was the lack of nuclear accumulation of the MAPK and the absence of a large-scale Hog1p-dependent transcriptional response with only four genes displaying Hog1p-dependent expression changes. Global analyses of Hog1p-dependent expression changes under heat and oxidative stress have not been reported. In contrast, exploring citric acid–induced expression changes by 2D analysis revealed only a small number of proteins (nine) that were affected by HOG1 deletion (Lawrence et al., 2004). It is possible that the timing and intensity of Hog1p signaling will be crucial to determine the type of response that various stressors produce.
Collectively, there is ample evidence that other agents beside osmotic stress can activate the HOG pathway, albeit with different timing and intensity. Moreover, the timing and intensity of MAPK signaling is likely to affect the output of the pathway. This is in analogy with other MAPK pathways in various yeasts, plants, and mammals.
Hog1p Affects Fps1p-dependent Metalloid Influx
A rapidly increasing number of proteins are being discovered that allow passage of nonessential toxic metals and metalloids into cells. However, little is known about how the activity of these transporters/channels is regulated (Ballatori, 2002; Tamás et al., 2005). To gain a complete understanding of the mechanisms of metalloid toxicity and tolerance acquisition as well as of their ability to serve as chemotherapeutic agents, it is of vital importance to identify the proteins that regulate the activity of such uptake pathways. Herein, we demonstrated that the yeast MAPK Hog1p mediates metalloid tolerance by affecting As(III) and probably also Sb(III) influx through the aquaglyceroporin Fps1p; As(III) sensitivity of hog1 was accompanied by elevated cellular arsenic levels, whereas the hog1 fps1 mutant had little As(III) influx and was as As(III) resistant as fps1. The phenotypes of hog1 and fps1 mutants on Sb(III) suggest that Hog1p also affects Fps1p-mediated Sb(III) influx. The fact that HOG1 deletion or increased Fps1p-dependent transport activity (by introducing the FPS1-1 allele) produced the same As(III) sensitivities and the same levels of As(III) uptake further corroborates this notion. Although aquaglyceroporins have been shown to constitute As(III)/Sb(III) entry routes in a number of organisms, this is (to our knowledge) the first report on a MAPK that controls the activity of an aquaporin/aquaglyceroporin.
How does Hog1p modulate Fps1p? Fps1p activity is regulated by a short N-terminal domain; deletion of, or mutation of specific residues within this domain results in a high level of unregulated transport activity (Tamás et al., 1999, 2003). Here, we demonstrated that Fps1p is phosphorylated in vivo on T231 within this N-terminal domain and that this phosphorylation critically affects Fps1p transport activity. Moreover, we provided evidence that Hog1p affects Fps1p phosphorylation in vivo and phosphorylates Fps1p-T231 in vitro. By using glycerol transport measurements we furthermore showed that Hog1p modulates basal Fps1p transport activity, i.e., in the absence of stress treatment. Interestingly, Hog1p also phosphorylates the Na+/H+ antiporter Nha1p and the Tok1p potassium channel in the absence of osmotic shock (Proft and Struhl, 2004). Taken together, these data would support a model where Hog1p modulates Fps1p activity under basal growth conditions, probably by phosphorylating T231. Such a homeostatic control mechanism would make sense because proliferating yeast cells need to monitor internal osmolarity and turgor pressure also in the absence of osmotic shock. Small fluctuations in osmolarity are likely to be effectively counteracted by adjusting intracellular Na+, K+, and glycerol levels through regulation of Nha1p, Tok1p, and Fps1p activity and would not necessitate a time- and energy-consuming large-scale transcriptional response.
Fps1p activity is osmo-regulated: it is rapidly inactivated in response to hyper-osmotic stress to allow glycerol accumulation and turgor recovery, whereas hypo-osmotic stress reactivates Fps1p to permit glycerol release and survival (Luyten et al., 1995; Tamás et al., 1999). Although the N-terminal tail is implicated in Fps1p regulation, the molecular details of this control remain unclear (Tamás et al., 1999, 2003). Here, we demonstrated that Hog1p controls the basal activity of Fps1p. However, other kinases might be involved in Fps1p control; HOG1 deletion did not fully abolish in vivo phosphorylation of Fps1p and the observed increase in Fps1p phosphorylation levels in response to As(III) (this work) and NaCl treatments (our unpublished data) was independent of Hog1p. These observations are consistent with previous data showing that rapid down-regulation of Fps1p transport activity (i.e., "closure" of Fps1p) occurs independently of Hog1p (Luyten et al., 1995; Tamás et al., 1999). Hence, other kinases may phosphorylate Fps1p on T231, at least in the absence of Hog1p, to regulate Fps1p activity. A complete understanding of Fps1p control in response to environmental stresses will require identification of the kinases and phosphatases that act on and regulate the activity of this aquaglyceoporin.
Other Roles of Hog1p under As(III) Stress
Our data indicated that Hog1p protects cells from As(III) toxicity through additional targets beside Fps1p; first, Hog1p modulates basal Fps1p activity; second, Hog1p is phosphorylated in As(III) exposed cells; and third, acr3 hog1 is more As(III)-sensitive than acr3 FPS1-1 cells. One such target might be the MAPKAP kinase Rck2p; deletion of RCK2 produces As(III) sensitivity, whereas its overexpression partially suppresses As(III) sensitivity of hog1 (Supplementary Figure 1). Interestingly, Rck2p does not modulate intracellular As(III) levels and hence does not affect As(III) tolerance through Fps1p (Thorsen and Tamás, unpublished data).
To conclude, metalloid-containing drugs are widely used in modern medical therapy. Arsenic trioxide is the active ingredient of Trisenox (Cell Therapeutics, Seattle, WA), the first line of treatment of acute promyelocytic leukemia. Similarly, all forms of leishmaniasis are treated with antimony-containing drugs and it is generally believed that the active form of antimony is Sb(III). Importantly, resistant Leishmania species as well as leukemic cells can be sensitized to metalloids by modulating their uptake through Leishmania and human aquaglyceroporins (Bhattacharjee et al., 2004; Gourbal et al., 2004). Our data demonstrate that a MAPK (Hog1p) can modulate the transport activity of an aquaglyceroporin (Fps1p) and suggest that down-regulation of MAPK activity may be an effective way to sensitize cells and to reverse metalloid resistance by increasing influx. A detailed understanding of how As(III)/Sb(III) uptake and toxicity is modulated may prove of value for the use of these metalloids in medical therapy.
|
ACKNOWLEDGMENTS |
|---|
|
Footnotes |
|---|
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org). 
This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E06-04-0315) on August 2, 2006.
Present addresses: 
Cell Biology and Biophysics Unit, EMBL, D-69117 Heidelberg, Germany;
Plant Pathology, Swammerdam Institute for Life Sciences, University of Amsterdam, 1090 GB, Amsterdam, The Netherlands.
Address correspondence to: Markus J. Tamás (markus.tamas{at}gmm.gu.se)
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Ballatori, N. (2002). Transport of toxic metals by molecular mimicry. Environ. Health Perspect 110, Suppl. 5, 689–694.[Medline]
Barrett, M. P., Burchmore, R. J., Stich, A., Lazzari, J. O., Frasch, A. C., Cazzulo, J. J., Krishna, S. (2003). The trypanosomiases. Lancet 362, 1469–1480.[CrossRef][Medline]
Bell, M. and Engelberg, D. (2003). Phosphorylation of Tyr-176 of the yeast MAPK Hog1/p38 is not vital for Hog1 biological activity. J. Biol. Chem 278, 14603–14606.
Bhattacharjee, H., Carbrey, J., Rosen, B. P., Mukhopadhyay, R. (2004). Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9. Biochem. Biophys. Res. Commun 322, 836–841.[CrossRef][Medline]
Bilsland-Marchesan, E., Arino, J., Saito, H., Sunnerhagen, P., Posas, F. (2000). Rck2 kinase is a substrate for the osmotic stress-activated mitogen-activated protein kinase Hog1. Mol. Cell. Biol 20, 3887–3895.
Bilsland, E., Molin, C., Swaminathan, S., Ramne, A., Sunnerhagen, P. (2004). Rck1 and Rck2 MAPKAP kinases and the HOG pathway are required for oxidative stress resistance. Mol. Microbiol 53, 1743–1756.[CrossRef][Medline]
Brewster, J. L., de Valoir, T., Dwyer, N. D., Winter, E., Gustin, M. C. (1993). An osmosensing signal transduction pathway in yeast. Science 259, 1760–1763.
Cavigelli, M., Li, W. W., Lin, A., Su, B., Yoshioka, K., Karin, M. (1996). The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15, 6269–6279.[Medline]
de Nadal, E., Casadome, L., Posas, F. (2003). Targeting the MEF2-like transcription factor Smp1 by the stress-activated Hog1 mitogen-activated protein kinase. Mol. Cell Biol 23, 229–237.
de Winde, J. H., Crauwels, M., Hohmann, S., Thevelein, J. M., Winderickx, J. (1996). Differential requirement of the yeast sugar kinases for sugar sensing in the establishment of the catabolite repressed state. Eur. J. Biochem 241, 633–643.[Medline]
Elbirt, K. K., Whitmarsh, A. J., Davis, R. J., Bonkovsky, H. L. (1998). Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J. Biol. Chem 273, 8922–8931.
Escoté, X., Zapater, M., Clotet, J., Posas, F. (2004). Hog1 mediates cell-cycle arrest in G1 phase by the dual targeting of Sic1. Nat. Cell Biol 6, 997–1002.[CrossRef][Medline]
Evens, A. M., Tallman, M. S., Gartenhaus, R. B. (2004). The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leuk. Res 28, 891–900.[CrossRef][Medline]
Ghosh, M., Shen, J., Rosen, B. P. (1999). Pathways of As(III) detoxification in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 96, 5001–5006.
Gourbal, B., Sonuc, N., Bhattacharjee, H., Legare, D., Sundar, S., Ouellette, M., Rosen, B. P., Mukhopadhyay, R. (2004). Drug uptake and modulation of drug resistance in leishmania by an aquaglyceroporin. J. Biol. Chem 279, 31010–31017.
Güldener, U., Heck, S., Fielder, T., Beinhauer, J., Hegemann, J. H. (1996). A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res 24, 2519–2524.
Haghnazari, E. and Heyer, W. D. (2004). The Hog1 MAP kinase pathway and the Mec1 DNA damage checkpoint pathway independently control the cellular responses to hydrogen peroxide. DNA Repair (Amst.) 3, 769–776.[Medline]
Haugen, A. C., Kelley, R., Collins, J. B., Tucker, C. J., Deng, C., Afshari, C. A., Brown, J. M., Ideker, T., Van Houten, B. (2004). Integrating phenotypic and expression profiles to map arsenic-response networks. Genome. Biol 5, R95.[CrossRef][Medline]
Jacoby, T., Flanagan, H., Faykin, A., Seto, A. G., Mattison, C., Ota, I. (1997). Two protein-tyrosine phosphatases inactivate the osmotic stress response pathway in yeast by targeting the mitogen-activated protein kinase, Hog1. J. Biol. Chem 272, 17749–17755.
Kyriakis, J. M. and Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev 81, 807–869.
Lawrence, C. L., Botting, C. H., Antrobus, R., Coote, P. J. (2004). Evidence of a new role for the high-osmolarity glycerol mitogen-activated protein kinase pathway in yeast: regulating adaptation to citric acid stress. Mol. Cell Biol 24, 3307–3323.
Liu, Z., Boles, E., Rosen, B. P. (2004). Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae. J. Biol. Chem 279, 17312–17318.
Liu, Z., Shen, J., Carbrey, J. M., Mukhopadhyay, R., Agre, P., Rosen, B. P. (2002). Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc. Natl. Acad. Sci. USA 99, 6053–6058.
Luyten, K., Albertyn, J., Skibbe, W. F., Prior, B. A., Ramos, J., Thevelein, J. M., Hohmann, S. (1995). Fps1, a yeast member of the MIP family of channel proteins, is a facilitator for glycerol uptake and efflux and is inactive under osmotic stress. EMBO J 14, 1360–1371.[Medline]
Maeda, T., Takekawa, M., Saito, H. (1995). Activation of yeast Pbs2 MAPKK by MAPKKKs or by binding of an SH3-containing osmosensor. Science 269, 554–558.
Maeda, T., Wurgler-Murphy, S. M., Saito, H. (1994). A two-component system that regulates an osmosensing MAP-kinase cascade in yeast. Nature 369, 242–245.[CrossRef][Medline]
Meng, Y. L., Liu, Z., Rosen, B. P. (2004). As(III) and Sb(III) uptake by GlpF and efflux by ArsB in Escherichia coli. J. Biol. Chem 279, 18334–18341.
Murray, H. W. (2001). Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob. Agents Chemother 45, 2185–2197.
O'Rourke, S. M. and Herskowitz, I. (2004). Unique and redundant roles for HOG MAPK pathway components as revealed by whole-genome expression analysis. Mol. Biol. Cell 15, 532–542.
Posas, F., Chambers, J. R., Heyman, J. A., Hoeffler, J. P., de Nadal, E., Arino, J. (2000). The transcriptional response of yeast to saline stress. J. Biol. Chem 275, 17249–17255.
Posas, F. and Saito, H. (1997). Osmotic activation of the HOG MAPK pathway via Ste11p MAPKKK: scaffold role of Pbs2p MAPKK. Science 276, 1702–1705.
Posas, F., Witten, E. A., Saito, H. (1998). Requirement of STE50 for osmostress-induced activation of the STE11 mitogen-activated protein kinase kinase kinase in the high-osmolarity glycerol response pathway. Mol. Cell. Biol 18, 5788–5796.
Posas, F., Wurgler-Murphy, S. M., Maeda, T., Witten, E. A., Thai, T. C., Saito, H. (1996). Yeast HOG1 MAP kinase cascade is regulated by a multistep phosphorelay mechanism in the SLN1-YPD1-SSK1 "two-component" osmosensor. Cell 86, 865–875.[CrossRef][Medline]
Proft, M., Pascual-Ahuir, A., de Nadal, E., Arino, J., Serrano, R., Posas, F. (2001). Regulation of the Sko1 transcriptional repressor by the Hog1 MAP kinase in response to osmotic stress. EMBO J 20, 1123–1133.[CrossRef][Medline]
Proft, M. and Struhl, K. (2004). MAP kinase-mediated stress relief that precedes and regulates the timing of transcriptional induction. Cell 118, 351–361.[CrossRef][Medline]
Raitt, D. C., Posas, F., Saito, H. (2000). Yeast Cdc42 GTPase and Ste20 PAK-like kinase regulate Sho1-dependent activation of the Hog1 MAPK pathway. EMBO J 19, 4623–4631.[CrossRef][Medline]
Reiser, V., Ruis, H., Ammerer, G. (1999). Kinase activity-dependent nuclear export opposes stress-induced nuclear accumulation and retention of Hog1 mitogen-activated protein kinase in the budding yeast Saccharomyces cerevisiae. Mol. Biol. Cell 10, 1147–1161.
Reiser, V., Salah, S. M., Ammerer, G. (2000). Polarized localization of yeast Pbs2 depends on osmostress, the membrane protein Sho1 and Cdc42. Nat. Cell Biol 2, 620–627.[CrossRef][Medline]
Rep, M., Krantz, M., Thevelein, J. M., Hohmann, S. (2000). The transcriptional response of Saccharomyces cerevisiae to osmotic shock: Hot1p and Msn2p/Msn4p are required for the induction of subsets of high osmolarity glycerol pathway-dependent genes. J. Biol. Chem 275, 8290–8300.
Rep, M., Proft, M., Remize, F., Tamás, M. J., Serrano, R., Thevelein, J. M., Hohmann, S. (2001). The Saccharomyces cerevisiae Sko1p transcription factor mediates HOG pathway-dependent osmotic regulation of a set of genes encoding enzymes implicated in protection from oxidative damage. Mol. Microbiol 40, 1067–1083.[CrossRef][Medline]
Rep, M., Reiser, V., Gartner, U., Thevelein, J. M., Hohmann, S., Ammerer, G., Ruis, H. (1999). Osmotic stress-induced gene expression in Saccharomyces cerevisiae requires Msn1p and the novel nuclear factor Hot1p. Mol. Cell Biol 19, 5474–5485.
Rodriguez-Gabriel, M. A. and Russell, P. (2005). Distinct signaling pathways respond to arsenite and reactive oxygen species in Schizosaccharomyces pombe. Eukaryot. Cell 4, 1396–1402.
Rosen, B. P. (2002). Transport and detoxification systems for transition metals, heavy metals and metalloids in eukaryotic and prokaryotic microbes. Comp. Biochem. Physiol. A. Mol. Integr. Physiol 133, 689–693.[CrossRef][Medline]
Sanders, O. I., Rensing, C., Kuroda, M., Mitra, B., Rosen, B. P. (1997). Antimonite is accumulated by the glycerol facilitator GlpF in Escherichia coli. J. Bacteriol 179, 3365–3367.
Schwartz, M. A. and Madhani, H. D. (2004). Principles of MAP kinase signaling specificity in Saccharomyces cerevisiae. Annu. Rev. Genet 38, 725–748.[CrossRef][Medline]
Singh, K. K. (2000). The Saccharomyces cerevisiae Sln1p-Ssk1p two-component system mediates response to oxidative stress and in an oxidant-specific fashion. Free Radic. Biol. Med 29, 1043–1050.[CrossRef][Medline]
Tamás, M. J., Karlgren, S., Bill, R. M., Hedfalk, K., Allegri, L., Ferreira, M., Thevelein, J. M., Rydström, J., Mullins, J. G., Hohmann, S. (2003). A short regulatory domain restricts glycerol transport through yeast Fps1p. J. Biol. Chem 278, 6337–6345.
Tamás, M. J., Labarre, J., Toledano, M. B., Wysocki, R. (2005). Mechanisms of toxic metal tolerance in yeast. In: In: Molecular Biology of Metal Homeostasis and Detoxification: From Microbes to Man, ed. M. J. Tamás and E. Martinoia. Heidelberg: Springer-Verlag, 395–454.
Tamás, M. J., et al. (1999). Fps1p controls the accumulation and release of the compatible solute glycerol in yeast osmoregulation. Mol. Microbiol 31, 1087–1104.[CrossRef][Medline]
Tamás, M. J., Rep, M., Thevelein, J. M., Hohmann, S. (2000). Stimulation of the yeast high osmolarity glycerol (HOG) pathway: evidence for a signal generated by a change in turgor rather than by water stress. FEBS Lett 472, 159–165.[CrossRef][Medline]
Tamás, M. J. and Wysocki, R. (2001). Mechanisms involved in metalloid transport and tolerance acquisition. Curr. Genet 40, 2–12.[CrossRef][Medline]
Teige, M., Scheikl, E., Reiser, V., Ruis, H., Ammerer, G. (2001). Rck2, a member of the calmodulin-protein kinase family, links protein synthesis to high osmolarity MAP kinase signaling in budding yeast. Proc. Natl. Acad. Sci. USA 98, 5625–5630.
Thomas, B. J. and Rothstein, R. (1989). Elevated recombination rates in transcriptionally active DNA. Cell 56, 619–630.[CrossRef][Medline]
Wagner, A. and Boman, J. (2004). Biomonitoring of trace elements in Vietnamese freshwater mussels. Spectrochim. Acta Part B 59, 1127–1134.
Warmka, J., Hanneman, J., Lee, J., Amin, D., Ota, I. (2001). Ptc1, a type 2C Ser/Thr phosphatase, inactivates the HOG pathway by dephosphorylating the mitogen-activated protein kinase Hog1. Mol. Cell. Biol 21, 51–60.
Widmann, C., Gibson, S., Jarpe, M. B., Johnson, G. L. (1999). Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev 79, 143–180.
Winkler, A., Arkind, C., Mattison, C. P., Burkholder, A., Knoche, K., Ota, I. (2002). Heat stress activates the yeast high-osmolarity glycerol mitogen-activated protein kinase pathway, and protein tyrosine phosphatases are essential under heat stress. Eukaryot. Cell 1, 163–173.
Wurgler-Murphy, S. M., Maeda, T., Witten, E. A., Saito, H. (1997). Regulation of the Saccharomyces cerevisiae HOG1 mitogen-activated protein kinase by the PTP2 and PTP3 protein tyrosine phosphatases. Mol. Cell. Biol 17, 1289–1297.[Abstract]
Wysocki, R., Bobrowicz, P., Ulaszewski, S. (1997). The Saccharomyces cerevisiae ACR3 gene encodes a putative membrane protein involved in arsenite transport. J. Biol. Chem 272, 30061–30066.
Wysocki, R., Chéry, C. C., Wawrzycka, D., Van Hulle, M., Cornelis, R., Thevelein, J. M., Tamás, M. J. (2001). The glycerol channel Fps1p mediates the uptake of arsenite and antimonite in Saccharomyces cerevisiae. Mol. Microbiol 40, 1391–1401.[CrossRef][Medline]
Wysocki, R., Fortier, P. K., Maciaszczyk, E., Thorsen, M., Leduc, A., Odhagen, A., Owsianik, G., Ulaszewski, S., Ramotar, D., Tamás, M. J. (2004). Transcriptional activation of metalloid tolerance genes in Saccharomyces cerevisiae requires the AP-1-like proteins Yap1p and Yap8p. Mol. Biol. Cell 15, 2049–2060.
Young, C., Mapes, J., Hanneman, J., Al-Zarban, S., Ota, I. (2002). Role of Ptc2 type 2C Ser/Thr phosphatase in yeast high-osmolarity glycerol pathway inactivation. Eukaryot. Cell 1, 1032–1040.
Yuzyuk, T., Foehr, M., Amberg, D. C. (2002). The MEK kinase Ssk2p promotes actin cytoskeleton recovery after osmotic stress. Mol. Biol. Cell 13, 2869–2880.
This article has been cited by other articles:
|
|
 |
|
  D. Hosiner, H. Lempiainen, W. Reiter, J. Urban, R. Loewith, G. Ammerer, R. Schweyen, D. Shore, and C. Schuller Arsenic Toxicity to Saccharomyces cerevisiae Is a Consequence of Inhibition of the TORC1 Kinase Combined with a Chronic Stress Response Mol. Biol. Cell, February 1, 2009; 20(3): 1048 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Westfall, J. C. Patterson, R. E. Chen, and J. Thorner Stress resistance and signal fidelity independent of nuclear MAPK function PNAS, August 26, 2008; 105(34): 12212 - 12217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Migdal, Y. Ilina, M. J. Tamas, and R. Wysocki Mitogen-Activated Protein Kinase Hog1 Mediates Adaptation to G1 Checkpoint Arrest during Arsenite and Hyperosmotic Stress Eukaryot. Cell, August 1, 2008; 7(8): 1309 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bermejo, E. Rodriguez, R. Garcia, J. M. Rodriguez-Pena, M. L. Rodriguez de la Concepcion, C. Rivas, P. Arias, C. Nombela, F. Posas, and J. Arroyo The Sequential Activation of the Yeast HOG and SLT2 Pathways Is Required for Cell Survival to Cell Wall Stress Mol. Biol. Cell, March 1, 2008; 19(3): 1113 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Mettetal, D. Muzzey, C. Gomez-Uribe, and A. van Oudenaarden The Frequency Dependence of Osmo-Adaptation in Saccharomyces cerevisiae Science, January 25, 2008; 319(5862): 482 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhao, R. Mehrabi, and J.-R. Xu Mitogen-Activated Protein Kinase Pathways and Fungal Pathogenesis Eukaryot. Cell, October 1, 2007; 6(10): 1701 - 1714. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mollapour and P. W. Piper Hog1 Mitogen-Activated Protein Kinase Phosphorylation Targets the Yeast Fps1 Aquaglyceroporin for Endocytosis, Thereby Rendering Cells Resistant to Acetic Acid Mol. Cell. Biol., September 15, 2007; 27(18): 6446 - 6456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thorsen, G. Lagniel, E. Kristiansson, C. Junot, O. Nerman, J. Labarre, and M. J. Tamas Quantitative transcriptome, proteome, and sulfur metabolite profiling of the Saccharomyces cerevisiae response to arsenite Physiol Genomics, June 19, 2007; 30(1): 35 - 43. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
